Zhang Linmei, Zhu Enzhao, Cao Shaokang, Ai Zisheng, Su Jiansheng
Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Tongji Research Institute of Stomatology, Department of Prosthodontics, Stomatological Hospital and Dental School, Tongji University, Shanghai, China.
School of Medicine, Tongji University, Shanghai, China.
Head Neck. 2025 Feb;47(2):517-528. doi: 10.1002/hed.27938. Epub 2024 Sep 20.
The use of postoperative radiotherapy (PORT) in patients with oral squamous cell carcinoma (OCSCC) lacks clear boundaries due to the non-negligible toxicity accompanying its remarkable cancer-killing effect. This study aims at validating the ability of deep learning models to develop individualized PORT recommendations for patients with OCSCC and quantifying the impact of patient characteristics on treatment selection.
Participants were categorized into two groups based on alignment between model-recommended and actual treatment regimens, with their overall survival compared. Inverse probability treatment weighting was used to reduce bias, and a mixed-effects multivariate linear regression illustrated how baseline characteristics influenced PORT selection.
4990 patients with OCSCC met the inclusion criteria. Deep Survival regression with Mixture Effects (DSME) demonstrated the best performance among all the models and National Comprehensive Cancer Network guidelines. The efficacy of PORT is enhanced as the lymph node ratio (LNR) increases. Similar enhancements in efficacy are observed in patients with advanced age, large tumors, multiple positive lymph nodes, tongue involvement, and stage IVA. Early-stage (stage 0-II) OCSCC may safely omit PORT.
This is the first study to incorporate LNR as a tumor character to make personalized recommendations for patients. DSME can effectively identify potential beneficiaries of PORT and provide quantifiable survival benefits.
口腔鳞状细胞癌(OCSCC)患者术后放疗(PORT)的使用缺乏明确界限,因为其显著的抗癌效果伴随着不可忽视的毒性。本研究旨在验证深度学习模型为OCSCC患者制定个性化PORT建议的能力,并量化患者特征对治疗选择的影响。
根据模型推荐的治疗方案与实际治疗方案的一致性将参与者分为两组,并比较他们的总生存期。采用逆概率治疗加权法减少偏差,混合效应多元线性回归说明了基线特征如何影响PORT选择。
4990例OCSCC患者符合纳入标准。混合效应深度生存回归(DSME)在所有模型和美国国立综合癌症网络指南中表现最佳。PORT的疗效随着淋巴结比率(LNR)的增加而提高。在老年、肿瘤较大、多个阳性淋巴结、舌部受累和IVA期患者中也观察到类似的疗效提高。早期(0-II期)OCSCC患者可安全地省略PORT。
这是第一项将LNR作为肿瘤特征为患者提供个性化建议的研究。DSME可以有效地识别PORT的潜在受益者,并提供可量化的生存益处。